Northeast Pharmaceutical Group Co., Ltd. (SZSE: 000597)
Health Care · Pharmaceuticals · CN
CN¥5.01
-0.40% today · -13.9% 1Y
Northeast Pharmaceutical Group Co., Ltd. (SZSE: 000597) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.06B and employs 5,727 people.
Over the last twelve months the share price has lost 13.9%, trading between 4.09 and 5.93.
Tweenvest scores Northeast Pharmaceutical Group Co., Ltd. across four factors: quality 72/100, value 49/100, growth 37/100, dividend 40/100. Its strongest factor is quality.
000597 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.06B
- Revenue (TTM)
- $1.03B
- P/E
- 28.65
- EPS
- 0.17
- Dividend yield
- 1.10%
- Beta (5Y)
- 0.06
- 52-week high
- CN¥5.93
- 52-week low
- CN¥4.09
- Avg volume (3M)
- —
- Shares outstanding
- 1.43B
- Employees
- 5,727
- Next earnings
- —
About Northeast Pharmaceutical Group Co., Ltd.
Northeast Pharmaceutical Group Co., Ltd., established in 1993 and headquartered in Shenyang, China, is a key manufacturer and supplier of active pharmaceutical ingredients (APIs) derived from both chemical synthesis and bio-fermentation. The company also develops and distributes various medicinal and micro-ecological preparation products within China. Its broad portfolio includes nutritional supplements such as Vitamin C and L-Carnitine, as well as specific APIs like fosfomycin and anti-AIDS compounds. Furthermore, it produces chemical goods, including pharmaceutical intermediates and chiral separation reagents. Beyond these, Northeast Pharmaceutical manufactures finished drugs for diverse applications, including digestives, narcotic medicines, and treatments for cardiovascular and cerebrovascular conditions. The group also maintains a significant presence in the medical distribution sector.
- ISIN
- CNE0000009G0
- Founded
- 1946
- Listed since
- May 23, 1996
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.